Your browser doesn't support javascript.
loading
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros, Tamara; Rigau, Marina; Chiva, Cristina; Montes, Melania; Garcia-Grau, Iolanda; Garcia, Marta; Diaz, Sherley; Celma, Ana; Bijnsdorp, Irene; Campos, Alex; Di Mauro, Primiano; Borrós, Salvador; Reventós, Jaume; Doll, Andreas; Paciucci, Rosanna; Pegtel, Michiel; de Torres, Inés; Sabidó, Eduard; Morote, Juan; Olivan, Mireia.
Afiliación
  • Sequeiros T; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Rigau M; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Chiva C; Proteomics Unit, Centre de Regulació Genòmica (CRG), Barcelona, Spain.
  • Montes M; Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain.
  • Garcia-Grau I; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Garcia M; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Diaz S; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Celma A; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Bijnsdorp I; Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Campos A; Department of Urology, VU University Medical Center, Amsterdam, The Netherlands.
  • Di Mauro P; Sanford-Burnham Medical Research Institute, La Jolla, California, USA.
  • Borrós S; Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain.
  • Reventós J; Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain.
  • Doll A; Departement of Basic Science, International University of Catalonia, Barcelona, Spain.
  • Paciucci R; IDIBELL-Bellvitge Biomedical Research Institute, Barcelona, Spain.
  • Pegtel M; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • de Torres I; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Sabidó E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Morote J; Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Olivan M; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
Oncotarget ; 8(3): 4960-4976, 2017 Jan 17.
Article en En | MEDLINE | ID: mdl-27903962
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Proteómica / Vesículas Extracelulares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Proteómica / Vesículas Extracelulares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos